tiprankstipranks
Trending News
More News >

New Ray Medicine Updates Nomination Committee Terms

Story Highlights
  • New Ray Medicine operates in the pharmaceutical industry, focusing on medical products.
  • The company updated its Nomination Committee terms to enhance governance and diversity.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
New Ray Medicine Updates Nomination Committee Terms

Don’t Miss TipRanks’ Half-Year Sale

New Ray Medicine International Holding Ltd. ( (HK:6108) ) has shared an announcement.

New Ray Medicine International Holding Ltd. has updated the terms of reference for its Nomination Committee, which is responsible for ensuring board diversity and compliance with listing rules. The committee, consisting of at least three members, aims to enhance governance by implementing a nomination policy that includes regular re-elections and diversity considerations, potentially impacting the company’s strategic direction and stakeholder engagement.

More about New Ray Medicine International Holding Ltd.

New Ray Medicine International Holding Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of medical products. The company is incorporated in Bermuda and listed on the Hong Kong Stock Exchange.

Average Trading Volume: 3,673,279

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$65.2M

Learn more about 6108 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1